Spyre Therapeutics, Inc. short interest in 2020
In 2020, Spyre Therapeutics, Inc.'s disclosed short interest ran from 0.72% of shares outstanding on 15 Jan 2020 to 3.85% on 31 Dec 2020, a change of +3.13 percentage points. The year's high was 6.81% on 15 Oct 2020 and its low 0.62% on 14 Feb 2020, averaging 3.03% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 24.22 days on 30 Nov 2020. Full history: Spyre Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 0.72% (15 Jan 2020)
- End of year
- 3.85% (31 Dec 2020)
- Change
- +3.13 pp
- High
- 6.81% (15 Oct 2020)
- Low
- 0.62% (14 Feb 2020)
- Average
- 3.03%
- Highest days to cover
- 24.22 (30 Nov 2020)
- SEC filings marked
- 9
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 0.72% | 6.19 | |
| 31 Jan 2020 | 0.84% | 4.70 | |
| 14 Feb 2020 | 0.62% | 3.76 | |
| 28 Feb 2020 | 0.72% | 3.26 | 10-K filed, results (8-K) |
| 13 Mar 2020 | 1.01% | 4.74 | |
| 31 Mar 2020 | 0.93% | 3.33 | |
| 15 Apr 2020 | 0.81% | 3.11 | |
| 30 Apr 2020 | 0.87% | 1.00 | results (8-K) |
| 15 May 2020 | 0.82% | 1.67 | 10-Q filed, results (8-K) |
| 29 May 2020 | 1.42% | 2.95 | |
| 15 Jun 2020 | 1.04% | 2.22 | |
| 30 Jun 2020 | 2.55% | 1.79 | |
| 15 Jul 2020 | 2.20% | 5.25 | |
| 31 Jul 2020 | 3.13% | 9.11 | |
| 14 Aug 2020 | 3.99% | 8.20 | 10-Q filed, results (8-K) |
| 31 Aug 2020 | 6.10% | 9.30 | |
| 15 Sep 2020 | 5.99% | 8.78 | |
| 30 Sep 2020 | 6.37% | 13.57 | |
| 15 Oct 2020 | 6.81% | 9.08 | |
| 30 Oct 2020 | 6.59% | 6.43 | |
| 13 Nov 2020 | 5.81% | 17.44 | 10-Q filed, results (8-K) |
| 30 Nov 2020 | 5.85% | 24.22 | |
| 15 Dec 2020 | 3.68% | 7.29 | |
| 31 Dec 2020 | 3.85% | 9.84 |
See also: Spyre Therapeutics, Inc.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.